Whereas some studies in experimental models of Parkinson’s and Alzheimer’s disease suggest that it can contribute to dopaminergic degeneration and Tau phosphorylation [74,75], others advocate neuroprotection through different mechanisms [76,77]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.